Ricin is a highly toxic compound derived from the castor bean plant, Ricinus communis. It is one of the deadliest poisons known to man, and has been used as a weapon of terror in the past. Ricin is a simple and inexpensive toxin to produce, making it a potential threat to public health and safety. In this article, we will explore the deadly potential of ricin, including its history, structure, and clinical effects.
Ricin has been known since antiquity, and was first described by the Greek physician Dioscorides in the first century AD. It was later used as a poison by the Byzantine Empire, and was reportedly used by the British during World War II. Ricin is also known to have been used as a weapon of terror in the past, including the assassination of Georgi Markov in 1978.
Ricin is a glycoprotein composed of two subunits, the A chain and the B chain. The A chain is responsible for the toxic effects of ricin, while the B chain is responsible for binding the toxin to cell membranes. Ricin can be produced from the castor bean plant, which is widely available and easy to grow. Ricin can also be extracted from the waste material produced during the processing of castor oil.
Ricin poisoning is a serious medical condition that can result in death if not treated promptly. Symptoms of ricin poisoning include nausea, vomiting, diarrhea, abdominal pain, and difficulty breathing. Severe cases can lead to multiple organ failure and death. Treatment of ricin poisoning is largely supportive, with the goal of preventing further absorption of the toxin and treating any complications that may arise.
Ricin is a highly toxic compound that has been used as a weapon of terror in the past. It is easy to produce and can be deadly if not treated promptly. Doctors should be aware of the deadly potential of ricin and be prepared to recognize and treat any cases of ricin poisoning that may arise.
1.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
2.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
3.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
4.
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer
5.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
1.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
2.
Is AI The New Radiologist For Breast MRI?
3.
Uncovering New Hope for Follicular Lymphoma Patients
4.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
5.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation